Clinical Trials Browser

Uterine Cervical Neoplasms, Endometriosis, Fallopian Tube Neoplasms, Metrorrhagia, Ovarian Neoplasms, Uterine Neoplasms, Uterine Prolapse, Endometrial Neoplasms

NCT07581288 2026-05-12

MIRA

Not yet recruiting

50 enrolled

Gynecologic

Endometrial Hyperplasia, Metrorrhagia, Uterine Hemorrhage, Uterine Neoplasms, Endometrial Neoplasms

NCT07072364 2026-05-01

Fibroid AUB

Phase NA Recruiting

154 enrolled

Gynecologic

Leiomyoma, Metrorrhagia, Uterine Hemorrhage

NCT07544680 2026-04-22

ENVISION

Recruiting

4,200 enrolled

GynecologicOther neoplasm

Endometrial Hyperplasia, Metrorrhagia, Precancerous Conditions, Endometrial Neoplasms

NCT06268626 2026-04-16

DETECTR

Recruiting

1,000 enrolled

Gynecologic

Metrorrhagia, Endometrial Neoplasms

NCT07397715 2026-02-12

MUSA3

Recruiting

1,000 enrolled

Gynecologic

Uterine Anomalies, Dysmenorrhea, Dyspareunia, Infertility, Menorrhagia, Metrorrhagia, Myoma, Abdominal Pain, Adenomyoma, Hemostatic Disorders, Adenomyosis

NCT07250178 2026-01-07

ONSD as an ICP Marker in vNOTES and TLH

Phase NA Completed

66 enrolled

Gynecologic

Metrorrhagia, Endometrial Neoplasms, Myofibroma

Clinical Trials

BARHYSTER

MIRA

Fibroid AUB

ENVISION

DETECTR

MUSA3

ONSD as an ICP Marker in vNOTES and TLH